EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBL-2H3 cells are an imprecise model for mast cell mediator release



RBL-2H3 cells are an imprecise model for mast cell mediator release



Inflammation Research 58(9): 611-618



The cell line, RBL-2H3, has been widely used as a mast cell model though much of the data is contradictory. The aim of this study is to assess the RBL-2H3 cell line as an in vitro model for degranulation studies. RBL-2H3 cells were stimulated with either dinitrophenylated-IgE, calcium ionophore A23187, compound 48/80, mast cell degranulating peptide or lipopolysaccharide and mediator (histamine, beta-hexosaminidase, interleukin-13 and TNF-alpha) release was analysed. Toll-like receptors (TLR) mRNA expression in RBL-2H3 cells and rat peritoneal mast cells (RPMC) were compared by RT-PCR. TLR4 and CD14 surface proteins in RBL-2H3 were analysed by FACS. Mediator release was dependent on media composition and degranulation was stimulated by IgE and A23187. Degranulation was inhibited by quercetin, but not by cromoglycate or ketotifen. Transcripts encoding TLR3-5 and 6 were detected in RBL-2H3 cells whereas TLR1-6 and TLR8 were clearly seen in RPMC. While proteins were detected for TLR4 in RBL-2H3 cells, CD14 was largely absent. While RBL-2H3 cells may be useful as a model for mast cell IgE-mediated degranulation, other aspects may not be representative and they may share similarities with basophils rather than with other histamine-releasing cell types.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333647

Download citation: RISBibTeXText

PMID: 19301096

DOI: 10.1007/s00011-009-0028-4



Related references

The human recombinant c kit receptor ligand rhscf induces mediator release from human cutaneous mast cells and enhances ige dependent mediator release from both skin mast cells and peripheral blood basophils. Journal of Immunology 149(2): 599-608, 1992

Stimulation of mast cell mediator release and interleukin-4 synthesis and secretion by cells of mast cell lineage in response to antigen provocation. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 199, 1995

Analysis of the effects of a range of mast cell stabilising compounds on soluble mediator release and cytokine gene induction from rat mast cells. Immunology 92(SUPPL 1): 65, 1997

The mediator release of rat peritoneal mast cells influenced by a pretreatment with homoepathically prepared histamine, one of the main mast cell granule contents. 1989

Bivalent effect of UV light on human skin mast cells-low-level mediator release at baseline but potent suppression upon mast cell triggering. Journal of Investigative Dermatology 124(2): 453-456, 2005

Brefeldin A blocks IL-6 and GM-CSF secretion, but not preformed mediator release from the human basophil/mast cell line KU-812 and mouse bone marrow-derived mast cells. FASEB Journal 12(4): A591, March 17, 1998

Reactivity of mast-cell-bound IgE idiotypes with anti-idiotypic antibody: mediator release or inhibition of antigen-induced mediator release?. International Archives of Allergy and Applied Immunology 91(2): 192-197, 1990

Inhibitory effects of low molecular weight heparin on mediator release by mast cells: Preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clinical and Experimental Immunology 110(3): 485-491, 1997

Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. Journal of Immunology 177(8): 4991-4997, 2006

Oxatomide and derivatives as inhibitors of mediator release from a mast cell model. Structure-activity relationships. Arzneimittel-Forschung 46(5): 496-501, 1996

Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release. Biochemical and Biophysical Research Communications 283(3): 707-714, 2001

IgE enhances Fce receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fce receptor I expression and mediator release. Journal of Immunology 162(9): 55-65, 1999